Abstract:This study aims to evaluate the efficacy of the standard agglutination test (SAT), the Brucellacapt test and enzyme-linked immunosorbent assay (ELISA) in clinical specimens collected from patients with suspected brucellosis. A prospective study was conducted from December 2020 to December 2021. Brucellosis was diagnosed on the basis of clinical evidence, and confirmed by isolation of Brucella or a four-fold rise in SAT titer. All samples were tested by the SAT, ELISA and the Brucellacapt test. Titers ≥1:100 were considered as SAT positive; ELISA was considered positive when an index greater than 11 was detected, while titers ≥1/160 indicated positivity on the Brucellacapt test. The specificity, sensitivity, and positive (PPVs) and negative predictive values (NPVs) of the three different methods were calculated. A total of 149 samples were collected from patients with suspected brucellosis. The sensitivities for the SAT, IgG, and IgM detection were 74.42%, 88.37% and 74.42%, respectively. The specificities were 95.24%, 93.65%, and 88.89%, respectively. The simultaneous measurement of IgG and IgM improved the sensitivity (98.84%) but reduced the specificity (84.13%) compared to each antibody test separately. The Brucellacapt test had excellent specificity (100%) and a high PPV (100%); however, the sensitivity and NPV were 88.37% and 86.30%, respectively. The combination of IgG detection by ELISA and the Brucellacapt test had excellent diagnostic performance, with 98.84% sensitivity and 93.65% specificity. This study showed that the simultaneous performance of IgG detection by ELISA and the Brucellacapt test has the potential to overcome the current limitations of detection. Brucellosis is an endemic zoonotic disease with significant impacts on public health worldwide. Early identification is crucial to reduce the rates of disability and mortality due to brucellosis. Human brucellosis is associated with a wide variety of clinical manifestations, making it difficult to diagnose clinically. Serological tests, which lack specificity and produce results that may be difficult to interpret, play a fundamental role in the diagnosis of this disease. Therefore, the combination of various serological tests may be helpful in ensuring the accuracy of diagnosis. Here, we aimed to explore the best combination among the SAT, ELISA and the Brucellacapt test to improve the efficiency of the diagnosis of human brucellosis.

Comparative analysis of the main outer membrane proteins of Brucella in the diagnosis of brucellosis

Study on antigenic protein Omp2b in combination with Omp31 and BP26 for serological detection of human brucellosis

The outer membrane proteins based seroprevalence strategy for Brucella ovis natural infection in sheep

Evaluation of Reactivity of Monoclonal Antibodies Against Omp25 of Brucella spp

Hybrid recombinant Omp 22, 25, and 31 immunodominant epitopes can be used for serodiagnosis of brucellosis

Evaluation of chimeric proteins for serological diagnosis of brucellosis in cattle

Development of a diagnostic indirect ELISA test for detection of Brucella antibody using recombinant outer membrane protein 16 kDa (rOMP16)

Serodiagnosis of human brucellosis by an indirect ELISA test using recombinant outer membrane protein 19 kDa (rOMP19) as an antigen

Recombinant Omp2b antigen-based ELISA is an efficient tool for specific serodiagnosis of animal brucellosis

Establishment of PCR for Detecting Bovine Brucella

Evaluation of the combined use of the recombinant Brucella abortus Omp10, Omp19 and Omp28 proteins for the clinical diagnosis of bovine brucellosis

Limitations of the BP26 protein-based indirect enzyme-linked immunosorbent assay for diagnosis of Brucellosis

Evaluation of recombinant 28 kDa outer membrane protein of Brucella abortus for the clinical diagnosis of bovine brucellosis in Korea

Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts

Production and evaluation of anti-BP26 monoclonal antibodies for the serological detection of animal brucellosis

Immunoproteomics of Brucella abortus reveals potential of recombinant antigens for discriminating vaccinated from naturally infected cattle

Paper-based ELISA diagnosis technology for human brucellosis based on a multiepitope fusion protein

Evaluating the efficacy of serological testing of clinical specimens collected from patients with suspected brucellosis

Recombinant OMP28 antigen-based indirect ELISA for serodiagnosis of bovine brucellosis

A Novel Multi-Epitope Recombined Protein for Diagnosis of Human Brucellosis

Comparative proteomic analysis of outer membrane vesicles from Brucella suis, Brucella ovis, Brucella canis and Brucella neotomae